Press Release: Biogen : QALSODY (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
/CNW/ - Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c))...
Read full article »
Biogen is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe.
Read more